NATIONAL ASSOCIATION OF MANUFACTURERS
JK
At a glance
Works on
Consumer Issues/Safety/ProductsCopyright/Patent/TrademarkDefenseEnergy/NuclearFinancial Institutions/Investments/SecuritiesFood Industry (safety, labeling, etc.)Government IssuesHealth IssuesHomeland SecurityImmigrationLabor Issues/Antitrust/WorkplaceManufacturingTariff (miscellaneous tariff bills)Taxation/Internal Revenue CodeTrade (domestic/foreign)
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Centers For Medicare and Medicaid Services (CMS)Commerce, Dept of (DOC)Consumer Product Safety Commission (CPSC)Council on Environmental Quality (CEQ)Energy, Dept ofEnvironmental Protection Agency (EPA)Export-Import Bank of the United States (EXIM Bank)Federal Energy Regulatory Commission (FERC)Federal Trade Commission (FTC)Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESInterior, Dept of (DOI)Internal Revenue Service (IRS)Intl Trade Administration (ITA)Natl Economic Council (NEC)Natl Labor Relations Board (NLRB)Natl Security Council (NSC)Natl Telecommunications & Information Administration (NTIA)Office of Science & Technology Policy (OSTP)SENATESecurities & Exchange Commission (SEC)State, Dept of (DOS)Treasury, Dept ofU.S. Customs & Border ProtectionU.S. Trade Representative (USTR)Vice President of the U.S.White House Office
Specific issues
168n Factory Deduction Corporate Alternative Minimum Tax (CAMT) HR 1 Business Tax Provisions Interest Expensing ATI Definition R&D Tax Credit Side-by-side international tax agreement Strategy Energy and Manufacturing Tax Credits
301 investigations and tariffs First Sale bill Agreements on Reciprocal Trade IEEPA tariffs Pharmaceutical tariffs Sec 232 steel and aluminum tariffs and derivatives USMCA
340B Reform Compounding Employer-sponsored insurance (including ICHRAs and AHPs) ERISA preemption FDA resourcing Health Savings Accounts Medicare Drug Price Negotiation Program Mergers and acquisitions Most Favored Nation/International Reference Pricing Nonprescription drugs PBM reform SAFE Drugs Act
AI technology exports Auto Sec 232 China Export-Import Bank Reauthorization Impact of Tariffs on Manufacturing Inputs Inclusions process Machinery and robotics Sec 232 Sec 232 pharma
Antitrust Policy Independent Contractor Rule Joint Employer Rule NLRB Nominations OSHA Heat Rule Right-to-repair
Artificial Intelligence Manufacturing workforce development Robotics
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →